Women enter pregnancy with unrecognised and untreated B12 deficiency
In the quiet arithmetic of early life, what a mother carries into pregnancy shapes what her child becomes. A rigorous trial spanning India and Nepal has found that pregnant vegetarian women who received higher doses of vitamin B12 gave birth to infants with measurably stronger cognitive development by their first year — a finding that illuminates a long-standing gap in antenatal care across South Asia, where B12 deficiency is common yet largely unaddressed by official health guidance.
- B12 deficiency is endemic among vegetarian women in South Asia, yet government antenatal programs remain focused on iron and folic acid — leaving a critical nutritional gap unaddressed at the most sensitive window of fetal brain development.
- A trial of 531 mother-infant pairs found that infants born to mothers taking 250 mcg of B12 daily scored significantly higher on cognitive assessments at 9–12 months, while mothers themselves saw biochemical deficiency fall by more than 30% compared to those on the lower dose.
- Motor development showed no meaningful difference between groups, but the cognitive gains were real — pointing specifically to B12's role in myelin formation and neurotransmitter synthesis during early neural architecture.
- Previous research on maternal B12 and infant neurodevelopment had been inconsistent, but this randomized, blinded, controlled trial offers the clearest evidence yet that higher supplementation produces better outcomes.
- The intervention is inexpensive, safe, and requires no new infrastructure — the barrier to action is not scientific or logistical, but a matter of whether health systems will update their guidelines to reflect what the evidence now shows.
A study conducted across India and Nepal has found that when pregnant vegetarian women take higher doses of vitamin B12, their babies show measurably better cognitive development in infancy. Published in BMJ Paediatrics Open, the randomized controlled trial followed 531 mother-infant pairs: half received 250 micrograms of B12 daily from early pregnancy through six months postpartum, the other half received 50 micrograms.
The results were clear in one domain and silent in another. Infants in the higher-dose group scored notably higher on mental development assessments at nine to twelve months. Motor development showed no meaningful difference. The mothers themselves also benefited — those on the larger dose saw biochemical B12 deficiency fall by more than 30 percent. It is the kind of finding that seems almost too simple, yet it addresses a gap that clinical practice has long overlooked.
Dr. Jitender Nagpal, who led the Indian portion of the research at Sitaram Bhartia Institute in Delhi, points to a stubborn reality: B12 deficiency is endemic across South Asia, particularly in vegetarian communities with limited access to animal-source foods. Yet routine antenatal care in India focuses almost exclusively on iron and folic acid. Women arrive at pregnancy already depleted — often unknowingly — at precisely the moment their developing babies are most vulnerable to nutritional gaps.
The timing is not incidental. Early brain development unfolds during pregnancy and the months immediately after birth, and B12 plays a direct role in myelin formation and neurotransmitter synthesis. When it is absent, that process falters. Previous research on whether maternal B12 supplementation improves infant neurodevelopment had been inconsistent, but this trial — rigorous in design, substantial in sample size, and blinded in assessment — offers firmer ground.
The intervention requires no new infrastructure and carries minimal cost. It would mean simply adding B12 to the nutrients already being monitored and supplemented in antenatal care. For a region where vegetarianism is culturally widespread and unrecognized deficiency is common, the public health implications are significant. The question that remains is whether health systems will move to act on what the evidence now clearly shows.
A study conducted across India and Nepal has found something straightforward but consequential: when pregnant vegetarian women take higher doses of vitamin B12, their babies show measurably better brain development in infancy. The research, published in BMJ Paediatrics Open, tracked 531 mother-infant pairs through a randomized controlled trial. Half the women received 250 micrograms of B12 daily from early pregnancy through six months postpartum. The other half received 50 micrograms. The difference in outcomes was significant enough to matter.
Babies born to mothers in the higher-dose group scored notably higher on mental development assessments when tested at nine to twelve months old. Motor development showed no meaningful difference between the groups, but the cognitive gains were real and measurable. Meanwhile, the mothers themselves benefited too: those taking the larger dose saw their biochemical B12 deficiency drop by more than 30 percent compared to the lower-dose group. It's the kind of finding that seems almost too simple—a single nutrient, a straightforward intervention, better outcomes—yet it addresses a gap that has been largely overlooked in clinical practice.
Dr. Jitender Nagpal, who led the Indian portion of the research at Sitaram Bhartia Institute of Science and Research in Delhi, points to a stubborn reality: B12 deficiency is endemic in South Asia, particularly among vegetarian populations with limited access to animal-source foods. Yet it remains a blind spot in routine antenatal care. Government guidelines and expert recommendations in India focus heavily on iron and folic acid supplementation during pregnancy. Vitamin B12 is conspicuously absent. Women arrive at pregnancy already depleted, often without knowing it, at precisely the moment when their developing babies are most sensitive to nutritional gaps.
The timing matters enormously. Early brain development unfolds during pregnancy and the months immediately after birth. A mother's nutritional status during this window shapes neural architecture in ways that can have lasting consequences. B12 plays a role in myelin formation—the insulation around nerve fibers—and in the synthesis of neurotransmitters. When it's missing, that process stutters. The study suggests it doesn't have to. The intervention is inexpensive, safe, and straightforward to implement.
What makes this finding particularly relevant is that it arrives amid inconsistent evidence from previous research on whether maternal B12 supplementation actually improves infant neurodevelopment, especially in low- and middle-income countries where deficiency rates are highest. This trial, with its rigorous design and substantial sample size, offers clearer ground. The researchers controlled for confounding factors, randomized participants, and used blinded assessment—the architecture of evidence that clinicians trust.
The implication is that B12 supplementation could become a routine, low-cost addition to antenatal care protocols. It wouldn't require new infrastructure or complex delivery mechanisms. It would simply mean including B12 alongside the nutrients already being monitored and supplemented. For a region where vegetarianism is culturally widespread and where many women of childbearing age carry unrecognized deficiency into pregnancy, the potential public health impact is substantial. The question now is whether health systems will act on what the evidence shows.
Citas Notables
Vitamin B12 remains poorly addressed in routine antenatal care, which continues to focus largely on iron and folic acid.— Dr. Jitender Nagpal, lead investigator
Optimising Vitamin B12 intake during pregnancy could be a simple, safe, and cost-effective addition to antenatal nutrition strategies.— Study findings
La Conversación del Hearth Otra perspectiva de la historia
Why has B12 been overlooked for so long in pregnancy care if it matters this much for brain development?
Because the focus has been on iron and folic acid—nutrients that prevent anemia and neural tube defects. Those are visible, measurable problems with established protocols. B12 deficiency is quieter. It doesn't always show up as anemia in the way iron deficiency does. And in vegetarian populations, it's been somewhat normalized, treated as an expected trade-off rather than a treatable condition.
But the study shows it's treatable and the dose difference is small—250 micrograms versus 50. That's not a dramatic intervention.
Exactly. That's what makes it compelling. You're not asking for a major overhaul. You're asking for a modest increase in a supplement that's already cheap and safe. The cognitive gains in the babies are measurable at nine to twelve months. We don't know yet how they persist, but early brain development is foundational.
What about the mothers themselves? Did they feel better?
The study measured biochemical markers—B12 levels in blood—not subjective symptoms. But yes, the mothers in the higher-dose group had significantly less deficiency. That matters for their own health too, not just the babies. B12 deficiency can cause neurological problems, fatigue, cognitive issues.
So this is really about two populations benefiting from one intervention.
Yes. And it's about a gap in guidelines that doesn't make sense given what we know. In India, B12 supplementation isn't in the government antenatal recommendations. Women arrive at pregnancy already depleted, and nobody's checking or correcting it.
What would it take to change that?
Evidence like this, combined with advocacy from clinicians like Dr. Nagpal who understand the burden of deficiency in their communities. But also political will—the recognition that antenatal care guidelines need updating, that vegetarian populations have specific nutritional needs that aren't being met.